DURECT Corporation Operating Cash Flow Margin

Operating Cash Flow Margin of DRRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Cash Flow Margin for the quarter ending June 30, 2023 was -448.97% (a -0.44% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow Margin increased by 2312.52%
  • Annual Operating Cash Flow Margin for 2022 was -136.29% (a -48.95% decrease from previous year)
  • Annual Operating Cash Flow Margin for 2021 was -266.95% (a 107.68% increase from previous year)
  • Annual Operating Cash Flow Margin for 2020 was -128.54% (a -390.35% decrease from previous year)
  • Twelve month Operating Cash Flow Margin ending June 30, 2023 was -150.54% (a -2.49% decrease compared to previous quarter)
  • Twelve month trailing Operating Cash Flow Margin increased by 20.86% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
-150.54% -154.38% -136.29% -124.56%
Visit stockrow.com/DRRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow Margin of DURECT Corporation

Most recent Operating Cash Flow Marginof DRRX including historical data for past 10 years.

Interactive Chart of Operating Cash Flow Margin of DURECT Corporation

DURECT Corporation Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -448.97% -450.97%
2022 -253.73% -18.61% -485.6% -290.29% -136.29%
2021 -152.27% -339.91% -353.1% -484.13% -266.95%
2020 -379.7% -479.78% -35.84% -806.27% -128.54%
2019 44.21% 174.57% -150.79% -136.92% 44.27%
2018 -1804.44% -12.78% -173.92% -191.74% -129.3%
2017 -38.04% 13.07% 289.28% -199.63% -2.73%
2016 -209.35% -155.78% -244.35% -176.97% -194.6%
2015 -116.24% -110.14% -95.86% -112.01% -108.94%
2014 -69.48% -109.18% -92.36% -43.13% -75.05%
2013 -90.51% -132.2% -108.93% -81.31% -100.8%
2012 -111.59% -71.45% -25.34%

Business Profile of DURECT Corporation

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic